| 101 |
21807635 | Resistance to CYP17A1 inhibition with abiraterone in castration-resistant prostate cancer: induction of steroidogenesis and androgen receptor splice variants. | 2011 Sep 15 |
2 |
| 102 |
21868758 | Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors. | 2011 Oct 15 |
4 |
| 103 |
20159824 | Phase I clinical trial of the CYP17 inhibitor abiraterone acetate demonstrating clinical activity in patients with castration-resistant prostate cancer who received prior ketoconazole therapy. | 2010 Mar 20 |
1 |
| 104 |
20399458 | A phase I clinical study of high dose ketoconazole plus weekly docetaxel for metastatic castration resistant prostate cancer. | 2010 Jun |
1 |
| 105 |
20550118 | Isopropylidene substitution increases activity and selectivity of biphenylmethylene 4-pyridine type CYP17 inhibitors. | 2010 Jul 8 |
1 |
| 106 |
20595043 | Molecular modeling on inhibitor complexes and active-site dynamics of cytochrome P450 C17, a target for prostate cancer therapy. | 2010 Jul 30 |
1 |
| 107 |
20684610 | Replacement of imidazolyl by pyridyl in biphenylmethylenes results in selective CYP17 and dual CYP17/CYP11B1 inhibitors for the treatment of prostate cancer. | 2010 Aug 12 |
1 |
| 108 |
19111799 | The Coffey Lecture: steroidogenic enzyme inhibitors and hormone dependent cancer. | 2009 Jan-Feb |
1 |
| 109 |
19211174 | Novel CYP17 inhibitors: synthesis, biological evaluation, structure-activity relationships and modelling of methoxy- and hydroxy-substituted methyleneimidazolyl biphenyls. | 2009 Jul |
1 |
| 110 |
19223900 | CYP17 blockade by abiraterone: further evidence for frequent continued hormone-dependence in castration-resistant prostate cancer. | 2009 Mar 10 |
1 |
| 111 |
19733987 | Beyond castration and chemotherapy: novel approaches to targeting androgen-driven pathways. | 2009 Oct 20 |
1 |
| 112 |
18672868 | Synthesis, biological evaluation, and molecular modeling of abiraterone analogues: novel CYP17 inhibitors for the treatment of prostate cancer. | 2008 Aug 28 |
2 |
| 113 |
18985049 | CYP17 inhibition as a hormonal strategy for prostate cancer. | 2008 Nov |
1 |